Habitat Radiomics Based on Dynamic Contrast‐Enhanced Magnetic Resonance Imaging for Assessing Axillary Lymph Node Burden in Clinical T1 – T2 Stage Breast Cancer: A Multicenter and Interpretable Study
Journal of Magnetic Resonance Imaging · 2025-09 · 62 (3) · 751-764
DOI: 10.1002/jmri.29796 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 21.04.2025. Verfasst von Siyi Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging, Contrast Media, Lymph Nodes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Hubei Provincial Natural Science Foundation and Xiangyang of China, National Natural Science Foundation of China, Science and technology Projects in Guangzhou.
Abstract (Originalsprache)
Background
Axillary lymph node burden(ALNB) is a critical factor in determining treatment strategies for clinical T 1 –T 2 (cT 1 –T 2 ) stage breast cancer. However, as ALNB assessment relies on invasive procedures, exploring non‐invasive methods is essential.
Purpose
To develop and validate a habitat radiomics model for assessing ALNB in cT 1 –T 2 breast cancer, incorporating radiogenomic data to improve interpretability. Study Type Retrospective. Population 468 patients with cT 1 –T 2 stage breast cancer from two institutions and The Cancer Imaging Archive (TCIA) and The Cancer Genome Atlas (TCGA)‐Breast Invasive Carcinoma (BRCA) were included. The cohort was divided into training ( n = 173), internal validation ( n = 58), external validation ( n = 130), and TCGA‐BRCA sets ( n = 107). Patients were categorized into high nodal burden (HNB; > 3 positive lymph nodes) and non‐HNB (≤ 3 positive lymph nodes) groups. Field Strength/Sequence 1.5‐T MRI and 3.0‐T MRI, and three‐dimensional dynamic contrast‐enhanced T1‐weighted gradient‐echo sequences. Assessment Two logistic regression models were developed using habitat‐based and clinical features. Model performance was evaluated using the AUC. SHapley Additive exPlanations (SHAP) analysis was employed to identify key features. Radiogenomic analysis, including gene set enrichment and drug sensitivity assessments, was conducted using transcriptomic data from the TCGA‐BRCA set. Statistical Tests Pearson correlation, Mann–Whitney U , genetic algorithm, logistic regression, AUC analysis, delong test, and SHAP analysis. A p ‐value < 0.05 was considered statistically significant.
Results
The Habitat model outperformed the Clinical model (AUCs: 0.840–0.932 vs. 0.558–0.673). The SHAP analysis was used to rank feature importance, with subregion 3 showing the highest average SHAP value. Radiogenomic analysis indicated upregulation of the KEGG ribosome pathway in the HNB group and identified differential drug sensitivity profiles among risk groups. Data Conclusion The Habitat model has the potential to assess ALNB in cT 1 –T 2 breast cancer and assist radiologists in axillary diagnosis, which may help reduce the need for unnecessary ALN dissection. Evidence Level: 3. Technical Efficacy: Stage 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, China.
- Department of Radiology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
- Shukun Technology Co., Ltd, Beijing, China.
- College of Computer Science and Technology, Zhejiang University of Technology, Zhejiang, China.
- Department of Ultrasound, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
- Philips Healthcare, Guangzhou, China.
ORCID-Profile: Junping Li
Förderung
- Hubei Provincial Natural Science Foundation and Xiangyang of China
- National Natural Science Foundation of China
- Science and technology Projects in Guangzhou
- Basic and Applied Basic Research Foundation of Guangdong Province
- Innovative Research Program of Xiangyang No. 1 People's Hospital
- Faculty Development Grants of Xiangyang No. 1 People's Hospital Affiliated to Hubei University of Medicine
- Guangzhou First People's Hospital Frontier Medical Technology Project
Zitieren
APA
Chen, S., Zhang, Y., Su, Y., Tian, J., Chen, Y., Tang, W., Fan, Y., Jin, C., He, Y., Xu, Y., Hu, H., Guo, Y., & Li, J. (2025). Habitat Radiomics Based on Dynamic Contrast‐Enhanced Magnetic Resonance Imaging for Assessing Axillary Lymph Node Burden in Clinical T1 – T2 Stage Breast Cancer: A Multicenter and Interpretable Study. Journal of Magnetic Resonance Imaging, 62(3), 751-764. https://doi.org/10.1002/jmri.29796
Vancouver
Chen S, Zhang Y, Su Y, Tian J, Chen Y, Tang W, et al. Habitat Radiomics Based on Dynamic Contrast‐Enhanced Magnetic Resonance Imaging for Assessing Axillary Lymph Node Burden in Clinical T1 – T2 Stage Breast Cancer: A Multicenter and Interpretable Study. Journal of Magnetic Resonance Imaging. 2025;62(3):751-764. doi:10.1002/jmri.29796
BibTeX
@article{Chen2025,
author = {Chen, Siyi and Zhang, Yue and Su, Yuqi and Tian, Jie and Chen, Yongxin and Tang, Wenjie and Fan, Yaheng and Jin, Chen and He, Yangcheng and Xu, Yongzhou and Hu, Hong and Guo, Yuan and Li, Junping},
title = {Habitat Radiomics Based on Dynamic Contrast‐Enhanced Magnetic Resonance Imaging for Assessing Axillary Lymph Node Burden in Clinical T1 – T2 Stage Breast Cancer: A Multicenter and Interpretable Study},
journal = {Journal of Magnetic Resonance Imaging},
year = {2025},
volume = {62},
number = {3},
pages = {751--764},
doi = {10.1002/jmri.29796}
}
EUVIMED